MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas

Phase 1
Completed
Conditions
Stage IV Lung Adenocarcinoma
Interventions
First Posted Date
2014-04-23
Last Posted Date
2023-01-26
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
30
Registration Number
NCT02120807
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States

and more 3 locations

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

Not Applicable
Completed
Conditions
Non-small Cell Lung Cancer (NSCLC)
Interventions
Device: Calypso Beacon Implantation
First Posted Date
2014-04-11
Last Posted Date
2024-07-03
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
48
Registration Number
NCT02111681
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Commack, Commack, New York, United States

🇺🇸

Memorial Sloan Kettering West Harrison, Harrison, New York, United States

and more 1 locations

Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer

Recruiting
Conditions
Advanced Cancer
Interventions
Behavioral: In-depth Patient Interviews
Behavioral: Adaptation of IMCP for Chinese Immigrant Cancer Patients
Behavioral: Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3 and Phase 4)
First Posted Date
2014-04-11
Last Posted Date
2024-12-13
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
93
Registration Number
NCT02112188
Locations
🇺🇸

MSK at Ralph Lauren (Limited Protocol Activities), New York, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 6 locations

Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases

Phase 1
Active, not recruiting
Conditions
Head and Neck Melanoma
Interventions
Drug: fluorescent cRGDY-PEG-Cy5.5-C dots
First Posted Date
2014-04-08
Last Posted Date
2024-05-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
67
Registration Number
NCT02106598
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Weill Cornell Medical Center, New York, New York, United States

ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2014-04-08
Last Posted Date
2023-05-26
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
9
Registration Number
NCT02106507
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

Active, not recruiting
Conditions
Hodgkin Lymphoma Survivor
Interventions
Other: Clinical Assessment
Procedure: Stress cardiac MRI
Procedure: Stress echocardiogram
First Posted Date
2014-04-08
Last Posted Date
2024-12-30
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
133
Registration Number
NCT02106611
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma

Not Applicable
Completed
Conditions
Neuroblastoma
Interventions
First Posted Date
2014-04-01
Last Posted Date
2020-02-28
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
69
Registration Number
NCT02100930
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Germ Cell Tumor and Testicular Tumor DNA Registry

Recruiting
Conditions
Germ Cell Tumor
Testicular Tumor
Interventions
Behavioral: Questionnaires
Other: sample of blood or saliva
First Posted Date
2014-03-31
Last Posted Date
2024-07-05
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
1000
Registration Number
NCT02099734
Locations
🇺🇸

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 5 locations

Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization

Not Applicable
Completed
Conditions
Tobacco Use Cessation
Interventions
Other: web-based video game (Quit IT)
Behavioral: Questionnaires
Other: Salvia sample
First Posted Date
2014-03-28
Last Posted Date
2020-12-30
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
50
Registration Number
NCT02099097
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Regorafenib in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2
Completed
Conditions
Adenoid Cystic Carcinoma
Interventions
First Posted Date
2014-03-28
Last Posted Date
2024-11-11
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
38
Registration Number
NCT02098538
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

🇺🇸

Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath